News
Starting Alzheimer’s Treatment Earlier Increases Benefits to Patients and Society
October 7, 2026
Featured Experts: Jack M. Chapel, PhD, Bryan Tysinger, PhD, Hossein Pourmand, DPPD, MBA, Dana Goldman, PhD, Paul Aisen, MD
Research
All Research Featured Research
News
GLP-1 Prescriptions for New Mothers Have Increased Sharply
October 1, 2026
Featured Experts: Sih-Ting Cai, PhD
Issue Brief
The Relationship Between GLP-1 Use and Trust in Pharmaceutical Companies
September 14, 2026
Featured Experts: Wändi Bruine de Bruin, MSc, PhD, Alison Sexton Ward, PhD, Dana Goldman, PhD
News
Pharmaceutical Spending Is Shifting Away From ‘Me-Too’ Drugs
August 3, 2026
Featured Experts: Darius Lakdawalla, PhD, Boshen Jiao, PhD, MPH
Perspective
Alzheimer’s Drugs Deserve a Second Opinion
July 13, 2026
Featured Experts: Paul Aisen, MD, Joseph Grogan, JD
Case Study
Schaeffer Solutions: Addressing the Obesity Crisis
June 25, 2026
Featured Experts: Dana Goldman, PhD, Darius Lakdawalla, PhD, Alison Sexton Ward, PhD, Erin Trish, PhD, Bryan Tysinger, PhD, PhuongGiang Nguyen, MSPH
Perspective
$2 Million Gene Therapy Cures Require a Financing Model
June 15, 2026
Featured Experts: William Padula, PhD
News
Medicare’s $35 Insulin Cap Lowered Beneficiary Costs, Increased Use for Some
June 8, 2026
Featured Experts: Rebecca Myerson, PhD, MPH, Dana Goldman, PhD
Evidence Base
How Medicare’s Evidence Requirements Create Barriers to Equitable Healthcare Access
June 4, 2026
Featured Experts: Alison Sexton Ward, PhD, Olivia Williams, Barry Liden, JD, Alice Chen, PhD, Desi Peneva, MS, Darius Lakdawalla, PhD
Perspective
When Cost-Effectiveness Thresholds Drift: Global HTA, MFN Pricing, and the Need for a Coherent Framework
May 28, 2026
Featured Experts: William Padula, PhD
Testimony
Testimony on Making Medicines More Affordable Through Competition
April 16, 2026
Featured Experts: Ryan Long
Comment Letter
Comments on Improving Transparency into Pharmacy Benefit Manager Fee Disclosure
April 15, 2026
Featured Experts: Geoffrey Joyce, PhD, Neeraj Sood, PhD
Perspective
Why Widespread Testing for Alzheimer’s Is Essential
April 6, 2026
Featured Experts: Dana Goldman, PhD
Perspective
Washington Is on the Verge of True PBM Reform
April 6, 2026
Featured Experts: Neeraj Sood, PhD
News
New Financing Models May Expand Access to Life-Changing Cell and Gene Therapies
March 19, 2026
Featured Experts: Alison Sexton Ward, PhD, Elizabeth Fowler, PhD, JD, Jeremy L. Shane, Darius Lakdawalla, PhD
Perspective
The Case for Expanding Access to Weight-Loss Medications
March 12, 2026
Featured Experts: Alison Sexton Ward, PhD
Comment Letter
Comments on Proposed GLOBE and GUARD Models
February 27, 2026
Featured Experts: Alice Chen, PhD, Darius Lakdawalla, PhD, Barry Liden, JD
Perspective
Trump Admin Takes Pro-Patient Approach to Drug Prices
February 26, 2026
Featured Experts: Joseph Grogan, JD